Guía de Actuación en Anafilaxia en Latinoamérica. Galaxia-Latam

Victoria Cardona, Alberto Álvarez-Perea, Ignacio Javier Ansotegui-Zubeldia, Alfredo Arias-Cruz, Juan Carlos Ivancevich, Sandra Nora González-Díaz, Patricia Latour-Staffeld, Mario Sánchez-Borges, Carlos Serrano, Dirceu Solé, Luciana Tanno, Nieves Cabañes-Higuero, Tomás Chivato, Belén De la Hoz, Montserrat Fernández-Rivas, Iker Gangoiti, Pedro Guardia-Martínez, Miguel Ángel Herranz-Sanz, Juan Carlos Juliá-Benito, Teófilo Lobera-Labairu, Manuel Praena-Crespo, José Ignacio Prieto-Romo, Carlos Sánchez-Salguero, José Ignacio Sánchez-González, Sonia Uixera-Marzal, Arantza Vega, Pedro Villarroel, Edgardo Jares

Resumen


La anafilaxia es una reacción alérgica grave de instauración rápida y potencialmente mortal. Sus manifestaciones clínicas son muy variadas, pudiendo afectar la piel, el sistema cardiovascular, el aparato respiratorio y el digestivo, entre otros. El tratamiento de elección, mediante la inyección intramuscular de adrenalina, debe ser precoz. Por lo anterior, es vital estar preparados para reconocerla adecuadamente. El objetivo de la presente guía de actuación clínica es mejorar el conocimiento de los profesionales sanitarios sobre anafilaxia y, consecuentemente, optimizar el tratamiento y manejo a largo plazo de esta entidad. La guía está adaptada a las peculiaridades de América Latina, especialmente en los aspectos relativos al tratamiento. Se destaca la necesidad de introducir los autoinyectores de adrenalina en los países que no dispongan de ellos.


Palabras clave


Anafilaxia; Reacción alérgica; Guía de práctica clínica; Adrenalina

Texto completo:

PDF PubMed (English)

Referencias


Sociedad Española de Alergología e Inmunología Clínic. Alergológica 2015. Factores epidemiológicos, clínicos y socioeconómicos de las enfermedades alérgicas en España. España: Sociedad Española de Alergología e Inmunología Clínica; 2017.

Ansotegui IJ, Sánchez-Borges M, Cardona V. Current trends in prevalence and mortality of anaphylaxis. Curr Treat Options Allergy. 2016;3(3):205-211. DOI: 10.1007/s40521-016-0094-0

Wood RA, Camargo CA, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(2):461-467. DOI: 10.1016/j.jaci.2013.08.016

Dhami S, Sheikh A. Anaphylaxis: epidemiology, aetiology and relevance for the clinic. Expert Rev Clin Immunol. 2017;13(9):889-895. DOI: 10.1080/1744666X.2017.1334552

Jares EJ, Baena-Cagnani CE, Sánchez-Borges M, Ensina LF, Arias-Cruz A, Gómez M, et al. Drug-induced anaphylaxis in Latin American countries. J allergy Clin Immunol Pract. 2015;3(5):780-788. DOI: 10.1016/j.jaip.2015.05.012

Cardona V, Álvarez-Perea A, Ansotegui IJ, Arias-Cruz A, González-Díaz SN, Latour-Staffeld P, et al. Management of anaphylaxis in Latin America: current situation. Rev Alerg Mex. 2017;64(2):171-177. DOI: 10.29262/ram.v64i2.250

Solé D, Ivancevich JC, Cardona V. Knowledge of anaphylaxis among ibero-American physicians: results of the Ibero-American Online Survey for Physicians on the management and treatment of anaphylaxis (IOSPTA) -Latin American Society of Allergy, Asthma & Immunology (LASAAI). J Investig Allergol Clin Immunol. 2013;23(6):441-443. Disponible en: http://www.jiaci.org/issues/vol23issue6/9-14.pdf

Solé D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LR, et al. Anaphylaxis in Latin American children and adolescents: the Online Latin American Survey on Anaphylaxis (OLASA). Allergol Immunopathol (Madr). 2012;40:331-335. DOI: 10.1016/j.aller.2011.09.008

Solé D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LR, et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clin (São Paulo). 2011;66(6):943-947. DOI: 10.1590/s1807-59322011000600004

Cardona Dahl V; Grupo de Trabajo de la Guía GALAXIA de actuación en anafilaxia. [Guideline for the management of anaphylaxis]. Med Clin (Barc). 2011;136(8):349-55. DOI: 10.1016/j.medcli.2010.10.003

Montoro-De Francisco A, Burgos-Pimentel A, Fonseca Avendaño J, De Vicente Jiménez T, De Mateo-Fernández B, Chivato-Pérez T. Formación básica en alergología: curso de anafilaxia. J Investig Allergol Clin Immunol. 2013;23(Supp 2):82.

Sala-Cunill A, Garriga-Baraut T, Cardona V, De la Torre F. Importancia de la formación específica sobre anafilaxia para la determinación del uso de autoinyectores de adrenalina (AIA). J Investig Allergol Clin Immunol. 2013;23(Suppl 2):182.

Cardona Dahl V, Cabañes Higuero N, Chivato Pérezc T, Guardia-Martínez P, Fernández-Rivas MM, Freijó-Martín C, et al. GALAXIA: Guía de Actuación en Anafilaxia 20176. España: ESMON Publicidad; 2016. DOI: 10.18176/944681-8-6

Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323(7308):334-336. DOI: 10.1136/bmj.323.7308.334

Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045. DOI: 10.1111/all.12437

AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18-23. DOI: 10.1136/qhc.12.1.18

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839-E842. DOI: 10.1503/cmaj.090449

Portier P, Richet C. De L’action anaphylactique de certains venins. C R Séances Soc Biol. 1902;54:170.

Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397. DOI: 10.1016/j.jaci.2005.12.1303

Simons FE, Ardusso LR, Bilò MB, Cardona V, Ebisawa M, El-Gamal YM, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014;7(1):9. DOI: 10.1186/1939-4551-7-9

Panesar SS, Javad S, De Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68(11):1353-1361. DOI: 10.1111/all.12272

Ibrahim I, Chew BL, Zaw WW, Van Bever HP. Knowledge of anaphylaxis among Emergency Department staff. Asia Pac Allergy. 2014;4(3):164-171. DOI: 10.5415/apallergy.2014.4.3.164

Wang J, Young MC, Nowak-Węgrzyn A. International survey of knowledge of food-induced anaphylaxis. Pediatr Allergy Immunol. 2014;25(7):644-650. DOI: 10.1111/pai.12284

Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Errores comunes en el tratamiento de pacientes con anafilaxia Common mistakes in the treatment of patients with anaphylaxis. Rev Alerg Mex. 2014;61(4):357-362.

Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161(1):15-21. DOI: 10.1001/archinte.161.1.15

Tejedor-Alonso MA, Moro-Moro M, Múgica-García MV. Epidemiology of anaphylaxis. Clin Exp Allergy. 2015;45(6):1027-1039. DOI: 10.1111/cea.12418

Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122(6):1161-1165. DOI: 10.1016/j.jaci.2008.09.043

Alonso MA, García MV, Hernández JE, Moro MM, Ezquerra PE, Ingelmo AR, et al. Recurrence of anaphylaxis in a Spanish Series. Eur PMC. 2013;23(6):383-391.

Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015;135(4):956-963.e1. DOI: 10.1016/j.jaci.2014.10.021

Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123(2):434-442. DOI: 10.1016/j.jaci.2008.10.049

Tanno LK, Bierrenbach AL, Calderon MA, Sheikh A, Simons FER, Demoly P, et al. Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision. Allergy. 2017;72(1):120-125. DOI: 10.1111/all.13006

Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med. 2004;164(3):317-319. DOI: 10.1001/archinte.164.3.317

Currie M, Kerridge RK, Bacon AK, Williamson JA. Crisis management during anaesthesia: anaphylaxis and allergy. Qual Saf Health Care. 2005;14(3):e19. DOI: 10.1136/qshc.2002.004465

Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am. 2007;27(2):309-326, viii. DOI: 10.1016/j.iac.2007.03.011

Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3(3):408-416.e1-e2. DOI: 10.1016/j.jaip.2014.12.010

Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005;115(3):584-591. DOI: 10.1016/j.jaci.2005.01.009

Brown AFT, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol. 2001;108(5):861-866. DOI: 10.1067/mai.2001.119028

Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez-Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397-1404. DOI: 10.1111/all.12475

Acero S, Tabar AI, Garcia BE, Echechipia S, Olaguibe JM. Anafilaxia: diagnóstico etiológico. Alergol Inmunol Clin. 1999;14(3):133-137. Disponible en: http://revista.seaic.org/junio99/133-137.pdf

Cosmes PM, Domínguez C, Moreno-Ancillo A. Anafilaxia en el norte de Extremadura. Alergol Inmunol Clin. 2002;17:8-12. Disponible en: http://revista.seaic.org/febrero2002/8-12.pdf

Fernández-Rivas M. Food allergy in Alergológica-2005. J Investig Allergol Clin Immunol. 2009;19(Suppl 2):37-44. Disponible en: http://www.jiaci.org/issues/vol19s2/7.pdf

Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology Services: Alergológica-2005. J Investig Allergol Clin Immunol. 2009;19(Suppl 2):45-50. DOI: http://www.jiaci.org/issues/vol19s2/8.pdf

Allen KJ, Koplin JJ. The epidemiology of IgE-mediated food allergy and anaphylaxis. Immunol Allergy Clin North Am. 2012;32(1):35-50. DOI: 10.1016/j.iac.2011.11.008

Sánchez J, Sánchez A. Epidemiology of food allergy in Latin America. Allergol Immunopathol (Madr). 2015;43(2):185-195. DOI: 10.1016/j.aller.2013.07.001

Pascal M, Grishina G, Yang AC, Sánchez-García S, Lin J, Towle D, et al. Molecular diagnosis of shrimp allergy: efficiency of several allergens to predict clinical reactivity. J Allergy Clin Immunol Pract. 2015;3(4):521-529. DOI: 10.1016/j.jaip.2015.02.001

Platts-Mills TA, Schuyler AJ, Hoyt AEW, Commins SP. Delayed anaphylaxis involving IgE to galactose-alpha-1,3-galactose. Curr Allergy Asthma Rep. 2015;15(4):12. DOI: 10.1007/s11882-015-0512-6

Muglia C, Kar I, Gong M, Hermes De Santis ER, Monteleone C. Anaphylaxis to medications containing meat byproducts in an alpha-gal sensitized individual. J Allergy Clin Immunol Pract. 2015;3(5):796-797. DOI: 10.1016/j.jaip.2015.04.004

Brown S, Kemp S, Lieberman P. Anaphylaxis. En: Adkinson N, Brochner B, Burks W, Busse W, Holgate S, Lemanske R, editores. Middleton’s Allergy: principles and practice. EE. UU.: Mosby Elsevier; 2013.

González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010;125(5):1098-1104.e1. DOI: 10.1016/j.jaci.2010.02.009

Techapornroong M, Akrawinthawong K, Cheungpasitporn W, Ruxrungtham K. Anaphylaxis: a ten years inpatient retrospective study. Asian Pac J Allergy Immunol. 2010;28(4):262-269. Disponible en: http://apjai-journal.org/wp-content/uploads/2017/12/8AnaphylaxisatenyearsVol28No4December2010P262.pdf

Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting: elicitors, therapy and incidence of severe allergic reactions. Allergy. 2012;67(11):1451-1456. DOI: 10.1111/all.12012

Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134(6):1318-1328.e7. DOI: 10.1016/j.jaci.2014.08.018

Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: Incidence and predictors of biphasic reactions. J Emerg Med. 2005;28(4):381-388. DOI: 10.1016/j.jemermed.2004.11.028

Gelincik A, Demirtürk M, Yılmaz E, Ertek B, Erdogdu D, Çolakoğlu B, et al. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol. 2013;110(2):96-100. DOI: 10.1016/j.anai.2012.11.018

Klein JS, Yocum MW. Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol. 1995;95(2):637-638. DOI: 10.1016/s0091-6749(95)70329-2

International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf. 2003;12(3):195-202. DOI: 10.1002/pds.822

Moro-Moro M, Tejedor-Alonso MA, Esteban-Hernández J, Múgica-García MV, Rosado-Ingelmo A, Vila-Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol. 2011;21(2):142-149. Disponible en: http://www.jiaci.org/issues/vol21issue2/9.pdf

Torres MJ, Ariza A, Mayorga C, Doña I, Blanca-Lopez N, Rondon C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol. 2010;125(2):502-505.e2. DOI: 10.1016/j.jaci.2009.11.032

Sánchez-Morillas L, Pérez-Ezquerra PR, Reaño-Martos M, Laguna-Martínez JJ, Sanz ML, Martínez LM. Selective allergic reactions to clavulanic acid: a report of 9 cases. J Allergy Clin Immunol. 2010;126(1):177-179. DOI: 10.1016/j.jaci.2010.03.012

Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret-Vautrin DA. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy. 2013;68(7):929-937. DOI: 10.1111/all.12168

Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010;40(1):15-31. DOI: 10.1111/j.1365-2222.2009.03404.x

Meng J, Rotiroti G, Burdett E, Lukawska JJ. Anaphylaxis during general anaesthesia: experience from a drug allergy centre in the UK. Acta Anaesthesiol Scand. 2017;61(3):281-289. DOI: 10.1111/aas.12858

Mertes PM, Alla F, Tréchot P, Auroy Y, Jougla E, Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011;128(2):366-373. DOI: 10.1016/j.jaci.2011.03.003

Kim MH, Lee SY, Lee SE, Yang MS, Jung JW, Park CM, et al. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock. PLoS One. 2014;9(6):e100154. DOI: 10.1371/journal.pone.0100154

Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175(3):621-628. DOI: 10.1148/radiology.175.3.2343107

Tankersley MS, Ledford DK. Stinging insect allergy: state of the art 2015. J allergy Clin Immunol Pract. 2015;3(3):315-322; quiz 323. DOI: 10.1016/j.jaip.2015.03.012

Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63(2):226-232. DOI: 10.1111/j.1398-9995.2007.01569.x

González-De Olano D, Álvarez-Twose I, Vega A, Orfao A, Escribano L. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis. Immunotherapy. 2011;3(5):637-651. DOI: 10.2217/imt.11.44

Antolín-Amérigo D, Ruiz-León B, Boni E, Alfaya-Arias T, Álvarez-Mon M, Barbarroja-Escudero J, et al. Component-resolved diagnosis in hymenoptera allergy. Allergol Immunopathol (Madr). 2018;46(3):253-262. DOI: 10.1016/j.aller.2017.05.003

Golden DBK. Insect sting anaphylaxis. Immunol Allergy Clin North Am. 2007;27(2):261-272. DOI: 10.1016/j.iac.2007.03.008

Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371-376. DOI: 10.1016/j.jaci.2004.04.029

Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy. 2007;62(8):857-871. DOI: 10.1111/j.1398-9995.2007.01421.x

Braganza SC, Acworth JP, Mckinnon DRL, Peake JE, Brown AFT. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child. 2006;91(2):159-163. DOI: 10.1136/adc.2004.069914

Patel BM, Bansal PJ, Tobin MC. Management of anaphylaxis in child care centers: evaluation 6 and 12 months after an intervention program. Ann Allergy Asthma Immunol. 2006;97(6):813-815. DOI: 10.1016/S1081-1206(10)60974-X

Novembre E, Cianferoni A, Bernardini R, Mugnaini L, Caffarelli C, Cavagni G, et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics. 1998;101(4):E8. DOI: 10.1542/peds.101.4.e8

Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy. 2003;33:1033-1040. DOI: 10.1046/j.1365-2222.2003.01671.x

Wölbing F, Fischer J, Köberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68(9):1085-1092. DOI: 10.1111/all.12193

Feldweg AM. Exercise-induced anaphylaxis. Immunol Allergy Clin North Am. 2015;35(2):261-275. DOI: 10.1016/j.iac.2015.01.005

Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384. DOI: 10.1056/NEJM199208063270603

Tunon De Lara JM, Villanueva P, Marcos M, Taytard A. ACE inhibitors and anaphylactoid reactions during venom immunotherapy. Lancet. 1992;340(8824):908. DOI: 10.1016/0140-6736(92)93314-d

Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol. 1988;81(1):1-5. DOI: 10.1016/0091-6749(88)90212-6

Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150. DOI: 10.1046/j.1365-2222.2000.00864.x

Summers CW, Pumphrey RS, Woods CN, McDowell G, Pemberton PW, Arkwright PD. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol. 2008;121(3):632-638. DOI: 10.1016/j.jaci.2007.12.003

Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. Reino Unido: Resuscitation Council; 2008.

Nolan JP, Soarb J, Zideman DA, Biarentd D, Deakinf C, Kosterg RW, et al. Guías para la Resucitación 2010 del Consejo Europeo de Resucitación (ERC). Eur Resusc Counc. 2010:1-167. Disponible en: https://www.cercp.org/guias-y-documentos/115-guias-erc-2010/file

Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust. 2006;185(5):283-289. DOI: 10.5694/j.1326-5377.2006.tb00563.x

Simons FER. 9. Anaphylaxis. J Allergy Clin Immunol. 2008;121(2 Suppl):S402-S407; quiz S420-470. DOI: 10.1016/j.jaci.2007.08.061

Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol. 2000;106(1 Pt 1):65-71. DOI: 10.1067/mai.2000.107600.

Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013;160(2):192-199. DOI: 10.1159/000339749

Brown SGA, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas. 2004;16:120-124. DOI: 10.1111/j.1742-6723.2004.00562.x

Enrique E, García-Ortega P, Sotorra O, Gaig P, Richart C. Usefulness of UniCAP-Tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy. 1999;54(6):602-606. DOI: 10.1034/j.1398-9995.1999.00882.x

Krishna MT, York M, Chin T, Gnanakumaran G, Heslegrave J, Derbridge C, et al. Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol. 2014;178(2):399-404. DOI: 10.1111/cei.12424

Belhocine W, Ibrahim Z, Grandné V, Buffat C, Robert P, Gras D, et al. Total serum tryptase levels are higher in young infants. Pediatr Allergy Immunol. 2011;22(6):600-607. DOI: 10.1111/j.1399-3038.2011.01166.x

Ono E, Taniguchi M, Mita H, Fukutomi Y, Higashi N, Miyazaki E, et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy. 2009;39(1):72-80. DOI: 10.1111/j.1365-2222.2008.03104.x

Gill P, Jindal NL, Jagdis A, Vadas P. Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis. J Allergy Clin Immunol. 2015;135(6):1424-1432. DOI: 10.1016/j.jaci.2015.04.019

Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008;358(1):28-35. DOI: 10.1056/NEJMoa070030

Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26(3):451-463. DOI: 10.1016/j.iac.2006.05.010

Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120(1 Suppl):2-24. DOI: 10.1016/j.jaci.2007.05.001

Kahveci R, Bostanci I, Dallar Y. The effect of an anaphylaxis guideline presentation on the knowledge level of residents. J Pak Med Assoc. 2012;62(2):102-106. Disponible en: https://jpma.org.pk/article-details/3246?article_id=3246

Nowak RM, Macias CG. Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med. 2014;127(1):S34-S44. DOI: 10.1016/j.amjmed.2013.09.012

Calva M, González-Díaz S, Arias Cruz A, et al. Epidemiology of anaphylaxis in adults treated in the emergency department, of the University Hospital of Monterrey N.L. Mexico, during 2005-2010. World Allergy Organ J. 2012;5(Suppl 2):104-105. DOI: 10.1097/01.WOX.0000412025.31760.d8

Simons FER, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13-37. DOI: 10.1097/WOX.0b013e318211496c

Simons FE, Ebisawa M, Sánchez-Borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1):32. DOI: 10.1186/s40413-015-0080-1

Campbell RL, Li JT, Nicklas RA, Sadosty AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599-608. DOI: 10.1016/j.anai.2014.10.007

ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005;112(24 Suppl):IV1-IV203. DOI: 10.1161/CIRCULATIONAHA.105.166550

Anchor J, Settipane RA. Appropriate use of epinephrine in anaphylaxis. Am J Emerg Med. 2004;22(6):488-490. DOI: 10.1016/j.ajem.2004.07.016

Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5(4):359-364. DOI: 10.1097/01.all.0000174158.78626.35

Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-873. DOI: 10.1067/mai.2001.119409

Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101(1 Pt 1):33-37. DOI: 10.1016/S0091-6749(98)70190-3

Brown SGA. The Pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am. 2007;27:165-175. DOI: 10.1016/j.iac.2007.03.003

Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115(3 Suppl 2):S483-S523. DOI: 10.1016/j.jaci.2005.01.010

Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB, et al. Management of anaphylaxis: a systematic review. Allergy. 2014;69(2):168-175. DOI: 10.1111/all.12318

Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-480.e1-42. DOI: 10.1016/j.jaci.2010.06.022

Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation. 2010;81(10):1400-1433. DOI: 10.1016/j.resuscitation.2010.08.015

Vanden-Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122(18 Suppl 3):S829-S861. DOI: 10.1161/CIRCULATIONAHA.110.971069

Spivey WH, Crespo SG, Fuhs LR, Schoffstall JM. Plasma catecholamine levels after intraosseous epinephrine administration in a cardiac arrest model. Ann Emerg Med. 1992;21(2):127-131. DOI: 10.1016/S0196-0644(05)80145-3

Burgert J, Gegel B, Loughren M, Ceremuga T, Desai M, Schlicher M, et al. Comparison of tibial intraosseous, sternal intraosseous, and intravenous routes of administration on pharmacokinetics of epinephrine during cardiac arrest: a pilot study. AANA J. 2012;80(4 Suppl):S6-S10.

Simons FE. First-aid treatment of anaphylaxis to food: Focus on epinephrine. J Allergy Clin Immunol. 2004;113(5):837-844. DOI: 10.1016/j.jaci.2004.01.769

Marone G, Bova M, Detoraki A, Onorati AM, Rossi FW, Spadaro G. The human heart as a shock organ in anaphylaxis. Novartis Found Symp. 2004;257:133-149; discussion 149-160, 276-285.

Fleming JT, Clark S, Camargo CA, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J allergy Clin Immunol Pract. 2015;3(1):57-62. DOI: 10.1016/j.jaip.2014.07.004

Anagnostou K, Harrison B, Iles R, Nasser S. Risk factors for childhood asthma deaths from the UK Eastern Region Confidential Enquiry 2001-2006. Prim Care Respir J. 2012;21(1):71-77. DOI: 10.4104/pcrj.2011.00097

Hourihane JO, Kilburn SA, Dean P, Warner JO. Clinical characteristics of peanut allergy. Clin Exp Allergy. 1997;27(6):634-639. DOI: 10.1111/j.1365-2222.1997.tb01190.x

Shadick NA, Liang MH, Partridge AJ, Bingham III CO, Wright E, Fossel AH, et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol. 1999;104(1):123-127. DOI: 10.1016/s0091-6749(99)70123-5

Noimark L, Wales J, Du Toit G, Pastacaldi C, Haddad D, Gardner J, et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy. 2012;42(2):284-292. DOI: 10.1111/j.1365-2222.2011.03912.x

Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol. 2011;127(4):852-854.e1-23. DOI:10.1016/j.jaci.2011.01.025

Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60(12):1459-1470. DOI: 10.1111/j.1398-9995.2005.00960.x

Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011;41(9):1201-1220. DOI: 10.1111/j.1365-2222.2011.03788.x

Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124(5):1047-1054. DOI: 10.1016/j.jaci.2009.08.027

Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ. 2006;333(7570):675. DOI: 10.1136/bmj.38905.634132.AE

Vander-Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000;137(6):749-755. DOI:10.1067/mpd.2000.109376

Ewan PW, Clark AT. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. Clin Exp Allergy. 2005;35(6):751-756. DOI: 10.1111/j.1365-2222.2005.02266.x

Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119(4):1016-1018. DOI: 10.1016/j.jaci.2006.12.622

Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119(4):1018-1019. DOI: 10.1016/j.jaci.2007.01.021

Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191-193. DOI: 10.1067/mai.2001.112031

Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol. 2005;115(3):575-583. DOI: 10.1016/j.jaci.2004.12.1122

Sicherer SH, Simons FER. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics. 2007;119(3):638-646. DOI: 10.1542/peds.2007-1033

Oren E, Banerji A, Clark S, Camargo CA. Food-induced anaphylaxis and repeated epinephrine treatments. Ann Allergy Asthma Immunol. 2007;99(5):429-432. DOI: 10.1016/S1081-1206(10)60568-6

Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol. 2006;117(2):464-465. DOI: 10.1016/j.jaci.2005.11.015

Järvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol. 2008;122(1):133-138. DOI: 10.1016/j.jaci.2008.04.031

Siracusa A, Folletti I, Gerth van Wijk R, Jeebhay MF, Moscato G, Quirce S, et al. Occupational anaphylaxis: an EAACI task force consensus statement. Allergy. 2015;70(2):141-152. DOI: 10.1111/all.12541.

Plumb B, Bright P, Gompels MM, Unsworth DJ. Correct recognition and management of anaphylaxis: not much change over a decade. Postgrad Med J. 2015;91(1071):3-7. DOI: 10.1136/postgradmedj-2013-132181

Bózzola CM, Saranz RJ, Lozano A, Cáceres ME, Sarraquigne P, Boudet RV, et al. Update on anaphylactic shock treatment recommendations: what’s new in the use of epinephrine?. Arch Argent Pediatr. 2015;113(1):81-87. DOI: 10.1590/S0325-00752015000100023

Pouessel G, Deschildre A, Castelain C, Sardet A, Sagot-Bevenot S, de Sauve-Boeuf A, et al. Parental knowledge and use of epinephrine auto-injector for children with food allergy. Pediatr Allergy Immunol. 2006;17(3):221-226. DOI:10.1111/j.1399-3038.2006.00391.x

Shah E, Pongracic J. Food-induced anaphylaxis: who, what, why, and where? Pediatr Ann. 2008;37(8):536-541.

Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, et al. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy. 2015;70(2):227-235. DOI: 10.1111/all.12548

Simons FE, Ardusso LR, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, et al. 2012 update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389-399. DOI: 10.1097/ACI.0b013e328355b7e4

Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-S55. DOI: 10.1016/j.jaci.2010.09.034

Rainbow J, Browne G. Fatal asthma or anaphylaxis? Emerg Med J. 2002;19(5):415-417. DOI: 10.1136/emj.19.5.415.

Kemp AM, Kemp SF. Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails. Curr Opin Allergy Clin Immunol. 2014;14(4):371-378. DOI: 10.1097/ACI.0000000000000080

Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J. 2005;22(4):272-273. DOI: 10.1136/emj.2005.023507

Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97(5):596-602. DOI: 10.1016/S1081-1206(10)61086-1

Boyce J a, Assa’ad A, Burks a W, et al. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol. 2010;126(6):1105-1118. DOI: 10.1016/j.jaci.2010.10.008

Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol. 2004;113(2):347-352. DOI: 10.1016/j.jaci.2003.10.053

Haymore BR, Carr WW, Frank WT. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc. 2005;26(5):361-365.

Heytman M, Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia. 2004;59(12):1210-1215. DOI: 10.1111/j.1365-2044.2004.03968.x

Schummer W, Schummer C, Wippermann J, Fuchs J. Anaphylactic shock: is vasopressin the drug of choice? Anesthesiology. 2004;101(4):1025-1027. DOI: 10.1097/00000542-200410000-00032

Liberman DB, Teach SJ. Management of anaphylaxis in children. Pediatr Emerg Care. 2008;24(12):861-6; quiz 867-9. DOI: 10.1097/PEC.0b013e31818ea116

De Miguel-Manzano B, Santiago-Guervós M, Candía B, Blanco-Hernández A, Muñoz-Alvarez D, Martín-Jiménez MT, et al. La historia clínica de urgencias. Un parámetro de la calidad de la asistencia. Emergencias. 1997;9(1):31-34.

Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet. 2001;357(9250):111-115. DOI: 10.1016/s0140-6736(00)03543-1

Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol. 2008;122:353-361. DOI: 10.1016/j.jaci.2008.05.028

Poon M, Reid C. Best evidence topic reports. Oral corticosteroids in acute urticaria. Emerg Med J. 2004;21(1):76-77. Disponible en: https://emj.bmj.com/content/emermed/21/1/76.full.pdf

Marques Ll, Baltasar MÀ, Granel C, Guspí R. Anafilaxia. En: Peláez A, Dávila, editores. Tratado de Alergología SEAIC. Madrid: ERGON; 2007.

Brown AF. Therapeutic controversies in the management of acute anaphylaxis. J Accid Emerg Med. 1998;15(2):89-95. DOI: 10.1136/emj.15.2.89

Barnett J, Botting N, Gowland MH, Lucas JS. The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad. Clin Transl Allergy. 2012;2(1):12. DOI: 10.1186/2045-7022-2-12

Macadam C, Barnett J, Roberts G, Stiefel G, King R, Erlewyn-Lajeunesse M, et al. What factors affect the carriage of epinephrine auto-injectors by teenagers? Clin Transl Allergy. 2012;2(1):3. DOI: 10.1186/2045-7022-2-3

Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol. 2000;106(1 Pt 1):171-176. DOI: 10.1067/mai.2000.106041

Kastner M, Harada L, Waserman S. Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature. Allergy. 2010;65(4):435-444. DOI: 10.1111/j.1398-9995.2009.02294.x




DOI: http://dx.doi.org/10.29262/ram.v66i6.588

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.